237 studies, 171 of them peer reviewed, and 195 comparing treatment and control groups, show that the anti-malaria drug significantly reduces mortality in Covid-19 patients, if treatment with Hydroxychloroquine starts early.
Like many issues surrounding the Wuhan-Coronavirus, Hydroxychloroquine was politicized early in 2020 after U.S. President Donald Trump suggested the affordable malaria drug showed promise in the treatment of Coronavirus-patients. Anti-Trump individuals both in the U.S. and abroad started defaming, and in some cases even banning, the drug, in response to the President’s support of it.
In the meantime, over 200 studies have proven Trump right, which is good news for Covid-patiens, as long as they can secure treatment with Hydroxychloroquine early on.